Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Hits Price Target Forecast with 24.45% Profit: QuantWave Analysis

August 28, 2023
ELI LILLY AND COMPANY has successfully achieved the price target forecast set by QuantWave, resulting in a significant profit of 24.45%. The forecast signal was issued on June 9, 2023, with the stock priced at $439.72 and a predicted long direction. On August 28, 2023, the target price of $547.25 was reached, confirming the accuracy of QuantWave's analytics.

This achievement reflects the effectiveness of QuantWave's forecasting capabilities and its value in assisting investors in making informed decisions. The movement of ELI LILLY AND COMPANY stock can be attributed to various factors, including positive industry trends, company performance, and market sentiment.

QuantWave, as an automated forecasting platform, provides users with predictions for a wide range of stocks, offering opportunities for potential profits. For those interested in delving deeper into investment strategies, QuantSchool offers comprehensive educational resources that unveil key principles for generating consistent income using the QuantWave forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

METAOctober 27, 2022QuantWave Successfully Achieves 24.83% Profit Target Forecast for Meta Platforms, Inc.  ~2 min.

On October 13, 2022, QuantWave, the automated forecasting platform, issued a short signal for META PLATFORMS, INC. (formerly known as Facebook, Inc.) with a price target of $97.41....

CMEMay 2, 2025QuantWave Successfully Hits Price Forecast for CME GROUP INC. with 13.5% Profit  ~1 min.

On February 20, 2025, QuantWave's automated forecasting platform issued a long signal for CME GROUP INC. with a price target of $279.17....

CMSAugust 1, 2024QuantWave Successfully Predicts CMS ENERGY CORPORATION Stock Price Target with 14.88% Profit  ~1 min.

On March 26, 2024, QuantWave, the automated forecasting platform, issued a long signal for CMS ENERGY CORPORATION with a price target forecast of 64.36 USD....

GSJanuary 21, 2025QuantWave Successfully Achieves 62.66% Profit Target for The Goldman Sachs Group, Inc. Stock  ~1 min.

QuantWave, the automated forecasting platform, has proven its accuracy once again as it successfully reached a price target forecast for The Goldman Sachs Group, Inc. stock....

WMTFebruary 26, 2024QuantWave Successfully Achieves Price Target Forecast for Walmart Inc., Generating 12.17% Profit  ~1 min.

QuantWave, the automated forecasting platform, recently accomplished a significant milestone by successfully reaching the price target forecast for Walmart Inc....